Patents by Inventor Vincent Tsiagbe

Vincent Tsiagbe has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Treatment of follicular lymphomas using inhibitors of the LT pathway
    Patent number: 8142779
    Abstract: Therapeutic uses of inhibitors of the lymphotoxin pathway to treat tumors, specifically to treat follicular lymphomas.
    Type: Grant
    Filed: October 13, 2009
    Date of Patent: March 27, 2012
    Assignees: Biogen Idec MA Inc., New York University
    Inventors: Jeffrey Browning, Jeanette Thorbecke, Vincent Tsiagbe
  • TREATMENT OF FOLLICULAR LYMPHOMAS USING INHIBITORS OF THE LT PATHWAY
    Publication number: 20100136000
    Abstract: Therapeutic uses of inhibitors of the lymphotoxin pathway to treat tumors, specifically to treat follicular lymphomas.
    Type: Application
    Filed: October 13, 2009
    Publication date: June 3, 2010
    Applicants: NEW YORK UNIVERSITY, BIOGEN IDEC MA INC.
    Inventors: Jeffrey BROWNING, Jeanette THORBECKE, Vincent TSIAGBE
  • Treatment of follicular lymphomas using inhibitors of the LT pathway
    Patent number: 7618933
    Abstract: Therapeutic uses of inhibitors of the Lymphotoxin Pathway to treat tumors, specifically to treat follicular lymphomas.
    Type: Grant
    Filed: April 25, 2006
    Date of Patent: November 17, 2009
    Assignees: New York University, Biogen Idec MA Inc.
    Inventors: Jeffrey L. Browning, Jeanette Thorbecke, Vincent Tsiagbe
  • Treatment of follicular lymphomas using inhibitors of the LT pathway
    Publication number: 20060280722
    Abstract: Therapeutic uses of inhibitors of the Lymphotoxin Pathway to treat tumors, specifically to treat follicular lymphomas.
    Type: Application
    Filed: April 25, 2006
    Publication date: December 14, 2006
    Applicants: Biogen Idec MA, Inc., New York University
    Inventors: Jeffrey Browning, Jeanette Thorbecke, Vincent Tsiagbe
  • Treatment of follicular lymphomas using inhibitors of the LT pathway
    Patent number: 7060667
    Abstract: Therapeutic uses of inhibitors of the Lymphotoxin Pathway to treat tumors, specifically to treat follicular lymphomas.
    Type: Grant
    Filed: July 26, 2000
    Date of Patent: June 13, 2006
    Assignees: Biogen Idec MA, Inc., New York University
    Inventors: Jeffrey Browning, Jeanette Thorbecke, Vincent Tsiagbe